MTB
BMRN icon

Mizuho Trust & Banking’s BioMarin Pharmaceuticals BMRN Stock Holding History

Mizuho Trust & Banking’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-253,537
Closed -$23.5M – 105
2016
Q3 		$23.5M Buy
253,537
+643
+0.3% +$60.5K 0.07% 305
2016
Q2 		$19.7M Buy
252,894
+876
+0.3% +$74.5K 0.06% 340
2016
Q1 		$20.8M Buy
252,018
+18,541
+8% +$1.51M 0.07% 316
2015
Q4 		$24.7M Buy
233,477
+802
+0.3% +$83.7K 0.08% 272
2015
Q3 		$24.5M Buy
232,675
+8,547
+4% +$1.14M 0.08% 257
2015
Q2 		$30.7M Buy
224,128
+4,413
+2% +$547K 0.1% 220
2015
Q1 		$27.4M Buy
219,715
+22,126
+11% +$2.34M 0.09% 249
2014
Q4 		$17.9M Buy
197,589
+11,646
+6% +$968K 0.06% 345
2014
Q3 		$13.5M Sell
185,943
-6,117
-3% -$402K 0.05% 409
2014
Q2 		$11.9M Buy
192,060
+8,853
+5% +$535K 0.04% 465
2014
Q1 		$12.5M Sell
183,207
-6,599
-3% -$486K 0.05% 435
2013
Q4 		$13.5M Buy
189,806
+22,000
+13% +$1.49M 0.05% 396
2013
Q3 		$9.36M Hold
167,806
– – 0.04% 497
2013
Q2 		$9.36M Buy
+167,806
New +$10.5M 0.04% 495

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mizuho Trust & Banking's BMRN Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2016, closing a stake of 253,537 shares — an estimated $23.5M sold.

Mizuho Trust & Banking first reported a position in BMRN in Q2 2013 and held it in 14 quarters. The position peaked at $30.7M in Q2 2015. 415 funds tracked by Wall St. Rank hold BMRN as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining BioMarin Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 253,537 BioMarin Pharmaceuticals shares in Q4 2016, an estimated $23.5M.
  • Mizuho Trust & Banking first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Mizuho Trust & Banking's BioMarin Pharmaceuticals position peaked at $30.7M in Q2 2015.
  • 415 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.